Mount Sinai Medical Center’s Wien Center for Alzheimer’s disease and Memory Disorders Provides Research and Access to Essential Care Not Available Elsewhere
With more than 5.4 million Americans suﬀering from Alzheimer’s disease, the Mount Sinai Wien Center for Alzheimer’s disease and Memory Disorders is focused on ﬁnding better treatment options to stop or slow the progression of the disease. The Wien Center’s multidisciplinary approach incorporates neurology, psychiatry, geriatrics and diagnostic imaging to develop successful medical responses to Alzheimer’s disease and other related memory disorders.
Mount Sinai Medical Center’s Wien Center provides holistic care for patients and their families, is actively involved in research and clinical trials, and oversees Florida’s Brain Bank Program. The Center had 3,250 patient visits in 2012 and hundreds more families and caregivers were provided much needed support.
“We are a hub for the study, diagnosis and treatment of Alzheimer’s disease,” says Ranjan Duara, MD, director of Mount Sinai’s Wien Center and a national expert on memory disorders. “Beyond the wide range of services that we provide for our patients and their families, we actively contribute to the broader base of medical knowledge and understanding of memory disorders.”
One current national study underway at Mount Sinai’s Wien Center involves amyloid imaging, using positron emission tomography (PET) scans to detect the presence and amount of amyloid protein in the brain. Among patients in which amyloid protein is detected in the brain, the risk for developing Alzheimer’s disease increases ﬁve- fold, yet some individuals with detectable brain amyloid do not develop the disease.
The Wien Center is studying why certain individuals with detectable brain amyloid do not develop Alzheimer’s. This information may help shed light on ways to prevent and or treat the disease. Additionally, the Wien Center is conducting a study of MRI scans and amyloid PET scans to determine how best to detect the earliest possible stages of Alzheimer’s disease. Determining the pace at which each patient develops the disorder will help researchers evaluate the success of treatment intended to slow the rate of mental decline.
The comprehensive research underway at the Wien Center provides critical intelligence to better understand the disease and gives patients the opportunity to receive additional care beyond traditional treatment. The Wien Center also provides year-round free memory screenings, which can oﬀer an early indication of cognitive impairment so that preventive care can begin as quickly as possible.
The Wien Center’s medical team understands that unless the entire family is cared for, individual patient care is often ineﬀective. With support from the State of Florida, they provide family and caregiver assistance through educational programs, seminars and group therapy sessions. The Wien Center also provides access to mental health counselors, social workers and community resources to assist patients and their caregivers.
In addition, Mount Sinai’s Wien Center participates in the Silver Alert program, which helps track missing seniors who suﬀer from dementia and other forms of cognitive impairment.
For over a decade, Mount Sinai’s Wien Center has hosted the Mild Cognitive Impairment Symposium, an international medical conference that focuses on advances in the study, diagnosis, prevention and treatment of memory disorders. Researchers from around the world attend the symposium to present the latest mild cognitive impairment scientiﬁc developments. The symposium also includes an open public educational forum.
“The Wien Center provides vital access to memory screenings, clinical trials, support groups and educational forums that are not widely available elsewhere, yet are essential to Florida’s aging population.”
– Steven D. Sonenreich, President and CEO of Mount Sinai Medical Center